Trials / Unknown
UnknownNCT01169168
Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome, Sepsis, Chronicle Liver Disease or After Lysis on Intensive Care Units
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In this study patients with 1. chronicle liver diseases * primary biliary cirrhosis * primary sclerosing cholangitis * alcoholic liver cirrhosis * hepatitis b or C * Wilson's disease * cryptogenic cirrhosis 2. Septic Inflammatory Response Syndrome (SIRS) * sepsis * septic shock 3. patients after lysis should be included Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods. The methods are: * Clauss fibrinogen * PT-Derived fibrinogen * immunoturbidimetric method * heat-precipitated fibrinogen * Schulz fibrinogen The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.
Conditions
Timeline
- Start date
- 2010-04-01
- First posted
- 2010-07-26
- Last updated
- 2010-07-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01169168. Inclusion in this directory is not an endorsement.